MicroVentures
VC Fund
Austin, United States
MicroVentures is an online equity crowdfunding platform enabling angel investors to connect with startups to raise capital. It connects accredited investors with startups, businesses, and services looking to raise funds or participate in select secondary market opportunities. The company provides founders access to early-stage capital andaccredited investors opportunities to invest in private equity. It prefers to invest in companies from the software, technology, telecommunications, and media sectors.MicroVentures was established in 2009 and is headquartered in Austin, Texas.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 12%
Last updated:
For AI agents: llms.txt
Industries MicroVentures invests in
Stages MicroVentures invests in
Countries MicroVentures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $350k–$5M
- Pre-Seed
- $700k–$1.2M
Investment Focus
Industry
- Software 8 (20%)
- 3D Printing 7 (17%)
- Mobile Apps 6 (15%)
- Finance 5 (12%)
- Biotechnology 5 (12%)
Stage
- Seed 24 (59%)
- Funding Round 5 (12%)
- Pre-Seed 3 (7%)
- Series A 2 (5%)
- Series B 2 (5%)
Country
- United States 31 (76%)
- India 4 (10%)
- Canada 1 (2%)
- Vietnam 1 (2%)
- Philippines 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bill Clark
CEO and Founder
|
CEO and Founder | Total investments: 0 | Find email | |
Ernesto Paiz
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Kelly Gore
Operations Analyst
|
Operations Analyst | Total investments: 0 | Find email | |
Lisa Blint
Compliance Analyst
|
Compliance Analyst | Total investments: 0 | Find email | |
Liz Meyer
Compliance & Operations Analyst
|
Compliance & Operations Analyst | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Remedium Bio
|
Remedium Bio is a Boston area gene therapy company focused on the development of curative treatments for a number of highly debilitating conditions. Our fundamental approach to product development utilizes proven technologies in novel ways to treat well-characterized disease pathology. To streamline R&D, we modularly apply elements of proventechnology to develop local, targeted treatments focusing on clinically validated molecules and mechanistic pathways. Today, our leading candidates include gene therapy treatments in the fields of Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke. | $2.3M / Seed / Aug 15, 2022 | |
Polco
|
Polco improves how local officials and constituents communicate through online verified surveys, polls, digital panels, and analytics. Polco is civic communication that counts. The company licenses Polco online verified polling profiles and premium content, services, and analytics to cities, counties, school districts, news media organizations, andother customers.It was founded in 2015 and headquartered in Middleton, Wisconsin. | $14.7M / Series A / Jul 01, 2022 | |
Impossible Metals
|
Impossible Mining is building underwater robotics vehicles which mine battery metals responsibly from the seabed. It transitions to carbon-neutral energies and will continue to demand critical metals in volumes. The company's dredge-based technology can’t - the preservation of the seafloor environment.Impossible Mining was established in2020 in Pasadena, California. | $10.1M / Seed / Jun 21, 2022 | |
AnFin
|
AnFin is a venture-backed fintech company building the most innovative products in the wealth management and brokerage space. We strongly believe in the power of the stock market to transform developing economies. Therefore, we want to democratize access to stocks, bonds, and structured investment products. By leveraging scalable technology andstrategic partnerships, AnFin plans to build an ecosystem of products that connect stakeholders in a seamless way. | $4.8M / Seed / Jun 21, 2022 | |
Encapsulate
|
Producing an effective chemotherapy solution with a fully automated tumor-on-a-chip, pre-prescription analysis. | $330K / Convertible Note / Apr 30, 2022 | |
Acorns
|
Acorns is a finance company that allows individuals to round up purchases and automatically invest the change. It allows customers to automatically invest in a low-cost, diversified portfolio of exchange-traded funds offered by some asset managers including Vanguard and BlackRock.Acorns was founded in 2012 and is headquartered in Irvine,California. | $300M / Series F / Mar 09, 2022 | |
CiSApp
|
CiSApp is a one-stop social media platform that considers the challenges of social media to create a solution that takes the industry to the next level. By bringing together the power and security of blockchain with a revolutionary business model that recognizes the importance of creating a truly safe, never-seen-before environment for contentcreators and users alike, CiSApp is the next big thing in the quickly growing social media industry. | $174.7K / Equity Crowdfunding / Nov 15, 2021 | |
BioSapien
|
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life. | $1.8M / Seed / Nov 11, 2021 | |
Bucha Bio
|
Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more.Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product. | $550K / Seed / Oct 18, 2021 | |
ODWEN
|
Enabling India’s 60m Small & Medium Enterprises to find curated warehouses in minutes at prices below current market and transport their inventory in and out with just a few clicks. | $2M / Seed / Oct 01, 2021 | |
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does MicroVentures invest in?
MicroVentures invests primarily in Software, 3D Printing and Mobile Apps startups, most often at Seed and Funding Round stage. Most of the 41 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is MicroVentures's check size?
MicroVentures typically joins rounds of $350k–$5M at Seed and $700k–$1.2M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds MicroVentures participates in.
How do I contact MicroVentures?
Public channels for MicroVentures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MicroVentures?
The team at MicroVentures includes Bill Clark (CEO and Founder), Ernesto Paiz (Venture Partner) and Kelly Gore (Operations Analyst), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
